Kayla R Iorga

Title: Kayla R Iorga: Innovator in Bile Acid Derivatives

Introduction

Kayla R Iorga is a notable inventor based in Dalzell, SC (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of bile acid derivatives. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Kayla R Iorga holds a patent for "Methods and intermediates for the preparation of bile acid derivatives." This invention relates to methods and novel intermediates useful in the preparation of a compound of formula (A) or a pharmaceutically acceptable salt thereof. The process involves converting the aldehyde of a compound of formula (B) with a reducing agent to prepare a compound of formula (C) and subsequently converting the compound of formula (C) with a sulfating reagent to prepare a compound of formula (A). The objective of this invention is to provide efficient methods for synthesizing bile acid derivatives that activate both FXR and TGR5.

Career Highlights

Kayla R Iorga has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Intercept Pharmaceuticals, Inc., where she continues to work on groundbreaking projects that aim to improve therapeutic options for patients.

Collaborations

Throughout her career, Kayla has collaborated with talented professionals, including Kevin Schaab and Paul E Whitley. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Kayla R Iorga is a pioneering inventor whose work in the preparation of bile acid derivatives has the potential to significantly impact the pharmaceutical industry. Her dedication to innovation and collaboration exemplifies the spirit of advancement in medical science.